Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | 0.01% | 90.69 | 1.3% | $838.74m | |
| AMGN | Amgen Inc. | 0.89% | 188.34 | 1.2% | $621.82m | |
| GILD | Gilead Sciences, Inc. | 1.84% | 67.59 | 0.9% | $512.40m | |
| BIIB | Biogen Inc. | 2.51% | 332.87 | 1.3% | $445.54m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.17% | 423.97 | 2.6% | $305.14m | |
| ILMN | Illumina, Inc. | 2.51% | 299.82 | 3.5% | $302.67m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.27% | 188.07 | 1.9% | $269.75m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.77% | 129.42 | 2.0% | $233.68m | |
| LOXO | Loxo Oncology Inc | -0.03% | 234.66 | 12.7% | $170.39m | |
| SRPT | Sarepta Therapeutics, Inc. | 2.65% | 138.45 | 15.4% | $148.57m | |
| A | Agilent Technologies, Inc. | 1.64% | 78.28 | 1.6% | $133.87m | |
| INCY | Incyte Corporation | 0.88% | 84.15 | 2.5% | $132.72m | |
| EXAS | Exact Sciences Corporation | 0.49% | 88.55 | 25.3% | $128.36m | |
| ARRY | Array BioPharma Inc. | 4.95% | 23.13 | 8.2% | $105.79m | |
| EXEL | Exelixis, Inc. | -0.18% | 22.26 | 6.4% | $97.74m |
Company Profile
Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy. It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. The company was founded by Ilan Ganot, Andrey Zarur, and Gilad Hayeem in March 2013 and is headquartered in Cambridge, MA.